Anti-mesothelin CAR T cell therapy (UTC Therapeutics Inc)

N/A

Report date: 2025/08/04 15:18:38

Base Information

Drug NameAnti-mesothelin CAR T cell therapy (UTC Therapeutics Inc)
Drug Alias Namemeso-CART
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAnti-Mesothelin
TargetsMesothelin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesUTC Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang University
Inactive CompaniesUTC Therapeutics Inc
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia